Press release
Oncology Biosimilars Market to Develop Rapidly by 2025
Besides this, leading pharmaceutical companies are entering into strategic alliances with leading generic manufacturers to develop biosimilars. A case in point is Biocon. The company entered into a strategic collaboration with Mylan to develop a strong portfolio of biosimilars, including recombinant proteins and monoclonal antibodies.
Cancer is considered the second-leading cause of death worldwide, says an analyst at TMR. Driven by the need to develop affordable treatment options for cancer, and various other factors, the global oncology biosimilars market is projected to expand at a phenomenal CAGR of 27.5% for the forecast period between 2017 and 2025. At this pace, the market that stood at US$2,100 mn in 2016 will become US$17,478.2 mn by the end of 2025.
Request to View Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14696
The G-CSF drug class segment led the market in 2016 in terms of revenue, and is anticipated to remain dominant over the forecast period. The growth of this segment is attributed to strong pipeline portfolio of key players in the biosimilars market. Hospital pharmacy led amongst key distribution channels in 2016 vis-à-vis revenue and the trend is expected to continue until the end of the forecast period in 2025.
Asia Pacific is a significant market for oncology biosimilars. A robust pipeline of biosimilars of key players in India, and practices of strategic alliances for the development and commercialization of biosimilars is expected to fuel the growth of Asia Pacific oncology biosimilars market.
Majorly fuelling the growth of oncology biosimilars market is the need to develop affordable therapies for the treatment of cancer. This is because cancer is presently the costliest health affair in terms of diagnosis as well as treatment. Pharmaceutical companies across the world are focused on developing biosimilars and generic medicines to combat cancer at all stages and for early detection of all types of malignancies.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14696
Oncology biosimilars are officially approved versions of oncology biologics that are cost-effective with similar efficacy and potency as original reference biologic. They differ from biologics in terms of manufacturing process and complexity, and can also be manufactured after the patent expiration of original reference biologic. This, along with a robust pipeline of biosimilars is expected to generate promising opportunities for the market in the next few years.
In Europe and Asia, Non-Hodgkin and neutropenia are the major disorders where oncology biosimilars are used. Apart from this, various biosimilars are in the pipeline for the treatment of breast cancer and lung cancer.
On the flip side, need for a complex infrastructure for the production of biosimilars and a lengthy process for biosimilars to receive approval from regulatory bodies are proving to be a roadblock to the market’s growth.
View Report -
https://www.transparencymarketresearch.com/oncology-biosimilars-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncology Biosimilars Market to Develop Rapidly by 2025 here
News-ID: 1016273 • Views: …
More Releases from Transparency Market Research
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B …
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energy…
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati …
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,…
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t …
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, and…
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b …
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multiple…
More Releases for TMR
Ophthalmic Drugs Market Reviews 2027 | TMR Study
Ophthalmic Drugs Market: Overview
According to Transparency Market Research's latest report on the global Ophthalmic Drugs Market for the historical period 2017-2018 and forecast period 2019-2027, Rising adoption of newly developed therapeutics in ophthalmology, Increasing incidence rates of eye related disorders, Advanced retinal treatment approvals for unmet needs in eye disorders, Significant awareness about the diagnosis and treatment of eye disorders are projected to drive the global Ophthalmic Drugs Market during the forecast period.
According…
Electronic Lab Notebook (ELN) Market | TMR Research
Global Electronic Lab Notebook (ELN) Market: Overview
Rising adoption of robotics and process automation in various business verticals, especially in healthcare sector is the prime reason for the growth of global electronic lab notebook (ELN) market. With ELN solutions it is now possible to set-up, execute and monitor the derived result in much lesser time. Owing to these benefit the global electronic lab notebook market in the forecast period of 2018…
Tumblers Market 2028 | TMR Research
The tumblers market is expected to set growth straight with rising demand for new attractive designs for liquors including alcoholic, and non-alcoholic in emerging region of Asia pacific. The rising disposable income, increasing access to quality products, and new product launches customised to suit the taste of the region promise major growth for the tumblers market in near future.
Download Brochure of This Market Report at - https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6200
Among regions, North America,…
Compound Chocolate Market 2018-2028 | TMR Research
Global Compound Chocolate Market: Overview
The demand within the global compound chocolate market has been rising on account of advancements in the field of confectioneries. The use of compound chocolate manufacture novel food products has played to the advantage of the global market. Compound chocolate is made up of cocoa and vegetable sweeteners, and this is the most unique trait of this form of chocolate. Several new and old vendors in…
Hyperloop Train Market 2025 | TMR Research
Global Hyperloop Train Market: Snapshot
The global market for hyperloop train is likely to exhibit high-speed expansion in the next few years. The demand for cheap and quick modes of transport that incur low base-costs and are built on easier-to-construct infrastructure, are immune to natural calamities such as earthquakes are the key factors expected to work in favor of the global hyperloop train market.
Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2000
The…
TMR - Research Reports
The torque sensor is a device that is used to measure and record torque on a rotating system. Torque monitoring and measurement are critical parameters in nearly all rotating parts, equipment and machines, which guarantees high performance. Torque monitoring is implemented by using torque systems. There are two types of torque systems - static and dynamic torque. Dynamic torque is tricky to measure and requires transfer of some form of…
